Xin S, Wen M, Tian Y, Dong H, Wan Z, Jiang S
World J Surg Oncol. 2025; 23(1):66.
PMID: 40016762
PMC: 11866629.
DOI: 10.1186/s12957-025-03701-9.
Quezada C, Samhitha S, Salas A, Ges A, Barraza L, Blanco-Lopez M
Nanomaterials (Basel). 2024; 14(16).
PMID: 39195399
PMC: 11357664.
DOI: 10.3390/nano14161361.
Dewarajan V, Elsayed N, Foo J, Tor Y, Low S, Chai W
Heliyon. 2024; 10(12):e33003.
PMID: 39021960
PMC: 11252712.
DOI: 10.1016/j.heliyon.2024.e33003.
Tai Q, Bao Y, Song N, Hu X, Duan L
J Thorac Dis. 2024; 16(1):604-614.
PMID: 38410570
PMC: 10894407.
DOI: 10.21037/jtd-23-1811.
Saviana M, Romano G, McElroy J, Nigita G, Distefano R, Toft R
Front Oncol. 2023; 13:1255527.
PMID: 37869089
PMC: 10585112.
DOI: 10.3389/fonc.2023.1255527.
Preoperative small pulmonary nodule localisation using hookwires or coils: strategy selection in adverse events.
Zuo T, Gao Z, Zhang T, Wen B, Chen B, Jiang P
J Cardiothorac Surg. 2023; 18(1):237.
PMID: 37488567
PMC: 10367412.
DOI: 10.1186/s13019-023-02301-6.
Proposing Specific Neuronal Epithelial-to-Mesenchymal Transition Genes as an Ancillary Tool for Differential Diagnosis among Pulmonary Neuroendocrine Neoplasms.
Prieto T, Baldavira C, Machado-Rugolo J, Olivieri E, da Silva E, Ab Saber A
Genes (Basel). 2022; 13(12).
PMID: 36553576
PMC: 9777553.
DOI: 10.3390/genes13122309.
[Clinical Progress in the Immunotherapy of Small Cell Lung Cancer].
Wang W, Zhang J, Li S
Zhongguo Fei Ai Za Zhi. 2022; 25(6):425-433.
PMID: 35747922
PMC: 9244506.
DOI: 10.3779/j.issn.1009-3419.2022.102.15.
Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor.
Jiang H, Zhang H
Onco Targets Ther. 2022; 15:587-596.
PMID: 35655605
PMC: 9153994.
DOI: 10.2147/OTT.S364545.
A case report of low grade fetal lung adenocarcinoma with TP53 mutation.
Wang B, Jin H
Medicine (Baltimore). 2022; 101(11).
PMID: 35356917
PMC: 10684199.
DOI: 10.1097/MD.0000000000029047.
Establishment and characterization of NCC-DMM1-C1, a novel patient-derived cell line of desmoplastic malignant pleural mesothelioma.
Noguchi R, Yoshimatsu Y, Ono T, Sei A, Motoi N, Yatabe Y
Oncol Lett. 2022; 23(2):64.
PMID: 35069873
PMC: 8756558.
DOI: 10.3892/ol.2021.13182.
and as Major Microbiota in Thymic Epithelial Tumors.
Higuchi R, Goto T, Hirotsu Y, Otake S, Oyama T, Amemiya K
J Pers Med. 2021; 11(11).
PMID: 34834444
PMC: 8623653.
DOI: 10.3390/jpm11111092.
Association of Mutation Profiles with Postoperative Survival in Patients with Non-Small Cell Lung Cancer.
Goto T, Kunimasa K, Hirotsu Y, Nakagomi T, Yokoyama Y, Higuchi R
Cancers (Basel). 2020; 12(11).
PMID: 33233456
PMC: 7700403.
DOI: 10.3390/cancers12113472.
Primary Driver Mutations in Specific to the Development of Thymomas.
Higuchi R, Goto T, Hirotsu Y, Yokoyama Y, Nakagomi T, Otake S
Cancers (Basel). 2020; 12(8).
PMID: 32722121
PMC: 7466068.
DOI: 10.3390/cancers12082032.
Localized biphasic malignant mesothelioma presenting as a giant pelvic wall mass: a rare case report and literature review.
Liu Y, Wu J, Zhao Y, Zhang P, Hua Z, Dong W
BMC Med Imaging. 2020; 20(1):48.
PMID: 32375654
PMC: 7203907.
DOI: 10.1186/s12880-020-00443-w.
New insights into small-cell lung cancer development and therapy.
Wang Y, Zou S, Zhao Z, Liu P, Ke C, Xu S
Cell Biol Int. 2020; 44(8):1564-1576.
PMID: 32281704
PMC: 7496722.
DOI: 10.1002/cbin.11359.
Identification of Clonality through Genomic Profile Analysis in Multiple Lung Cancers.
Higuchi R, Nakagomi T, Goto T, Hirotsu Y, Shikata D, Yokoyama Y
J Clin Med. 2020; 9(2).
PMID: 32093372
PMC: 7074554.
DOI: 10.3390/jcm9020573.
[Clinical Characteristics, Treatment and Prognosis of 47 Non-small Cell Lung Cancer with Neuroendocrine Differentiation Patients].
Li X, Xu H, Kang X, Zhao J, Lin Y, Wang S
Zhongguo Fei Ai Za Zhi. 2019; 22(8):507-511.
PMID: 31451141
PMC: 6717869.
DOI: 10.3779/j.issn.1009-3419.2019.08.05.
Clinical Implications of Noncoding Indels in the Surfactant-Encoding Genes in Lung Cancer.
Nakagomi T, Hirotsu Y, Goto T, Shikata D, Yokoyama Y, Higuchi R
Cancers (Basel). 2019; 11(4).
PMID: 30999697
PMC: 6520783.
DOI: 10.3390/cancers11040552.
Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3.
Nakagomi T, Goto T, Hirotsu Y, Shikata D, Yokoyama Y, Higuchi R
Cancers (Basel). 2018; 10(12).
PMID: 30513627
PMC: 6316015.
DOI: 10.3390/cancers10120478.
